The best course of action for those affected with congestive heart failure, which affects millions of Americans, is most often a heart valve transplant. Since the condition is so prevalent, however, there are seldom enough donors to meet the rising demand for replacement valves.
Thanks to recent funding given to the University of California, San Diego, those affected by congestive heart failure may have renewed hope in the form of ongoing stem cell bioresearch projects.
Read More
